Editas Medicine vs Orchard Therapeutics

Editas Medicine vs Orchard Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Editas Medicine is on 42/100 and Orchard Therapeutics on 51/100.

Editas Medicine logo
Editas MedicineA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Try Editas Medicine
Orchard Therapeutics logo
Orchard TherapeuticsGene therapy company developing treatments for rare inherited diseases.
Try Orchard Therapeutics

Where each one leads

Editas Medicine

  • funding raised: $210M against $125M

Orchard Therapeutics

  • our overall score: 51/100 against 42/100
  • headcount: 248 against 185

At a glance

MeasureEditas MedicineOrchard Therapeutics
What it isA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.Gene therapy company developing treatments for rare inherited diseases.
CategoryBiotech, MedTech, Genomics, Drug DiscoveryBiotech, MedTech, HealthTech, Genomics
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20132015
HeadquartersCambridge, United StatesBoston, United States
StatusActiveActive

Size, funding and growth

MeasureEditas MedicineOrchard Therapeutics
Employees185248
Total funding$210M$125M
Latest roundSeries BIPO
LinkedIn followers52,61654,964

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEditas MedicineOrchard Therapeutics
StartupHub scoreOur 0-100 rating42/10051/100
Traction60/10060/100
TeamNot published30/100
Search visibility27/10025/100
Quality45/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (39/100)
Domain ratingLink authority, 0-10061/10060/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEditas MedicineOrchard Therapeutics
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJquery, Tailwind CSS, BootstrapJquery
AnalyticsGoogle Tag ManagerGoogle Tag Manager

Editas Medicine vs Orchard Therapeutics: common questions

Which is better, Editas Medicine or Orchard Therapeutics?

On our 0-100 score Orchard Therapeutics rates higher (51/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Editas Medicine and Orchard Therapeutics compare on the numbers?

Editas Medicine leads on funding raised ($210M against $125M). Orchard Therapeutics leads on our overall score (51/100 against 42/100), headcount (248 against 185).

Read the full Editas Medicine review and pricing or the Orchard Therapeutics review and pricing. You can also browse other Editas Medicine alternatives we track.